Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Kelly

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
The Journal of Biological Chemistry|September 18, 2001
ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cellsA C Keates, S Keates, J H Kwon, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2017
Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free dietS Mahadev, J A Murray, T-T Wu, et al.
Infection and Immunity|November 12, 2014
Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infectionZ Zhang, X Chen, L D Hernandez, et al.
Infection and Immunity|November 12, 2015
Correction for Zhang et al., Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infectionZ Zhang, X Chen, L D Hernandez, et al.
The American Journal of Gastroenterology|July 25, 2012
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challengeDaniel A Leffler, C P Kelly, H Z Abdallah, et al.
The Journal of Clinical Investigation|August 1, 1996
Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin AC Pothoulakis, R J Gilbert, C Cladaras, et al.
Infection and Immunity|June 4, 2008
Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cellsA C Keates, S Tummala, R M Peek, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2013
Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors' replyC P Kelly, P H R Green, J A Murray, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2012
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled studyC P Kelly, P H R Green, J A Murray, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2016
Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registryA Rubio-Tapia, G Malamut, W H M Verbeek, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Journal of Biological Chemistry|September 18, 2001
ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cellsA C Keates, S Keates, J H Kwon, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2017
Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free dietS Mahadev, J A Murray, T-T Wu, et al.
Infection and Immunity|November 12, 2014
Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infectionZ Zhang, X Chen, L D Hernandez, et al.
Infection and Immunity|November 12, 2015
Correction for Zhang et al., Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infectionZ Zhang, X Chen, L D Hernandez, et al.
The American Journal of Gastroenterology|July 25, 2012
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challengeDaniel A Leffler, C P Kelly, H Z Abdallah, et al.
The Journal of Clinical Investigation|August 1, 1996
Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin AC Pothoulakis, R J Gilbert, C Cladaras, et al.
Infection and Immunity|June 4, 2008
Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cellsA C Keates, S Tummala, R M Peek, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2013
Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors' replyC P Kelly, P H R Green, J A Murray, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2012
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled studyC P Kelly, P H R Green, J A Murray, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2016
Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registryA Rubio-Tapia, G Malamut, W H M Verbeek, et al.
Pageof 10